array biopharma inc (ARRY:NASDAQ GM)
Kirby L. Cramer
Former Director, Array BioPharma, Inc.
|Age||Total Calculated Compensation||This person is connected to 30 board members in 5 different organizations across 11 different industries.|
See Board Relationships
Mr. Kirby L. Cramer is the President at Keystone Capital Company. Mr. Cramer served as Chief Executive Officer of Hazleton Laboratories Corporation from 1968 to 1987. Mr. Cramer served as a Manager of DonJoy, L.L.C., the predecessor of DJ Orthopedics Inc. from December 1999 to November 2001. He serves as Chairman of The Harris Trust Company. Mr. Cramer has been Chairman Emeritus of Hazleton Laboratories Corporation since 1991. Mr. Cramer is a Director at Applied Bioscience ...
3200 Walnut StreetPhone: 303-381-6600
Boulder, Colorado 80301
Board Members Memberships*
Member of the Board of Directors
Former Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Former Chairman Emeritus, Member of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Transaction Committee
Former Executive Director
Former Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Former Chairman, Chairman of Compensation Committee and Member of Nominating and Corporate Governance Committee
Harvard Business School
University of Washington
Honorary Doctorate 1988
James Madison University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Jack Lief Ph.D.||Co-Founder, Chairman, Chief Executive Officer and President|
Arena Pharmaceuticals, Inc.
|Harvey J. Berger M.D.||Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee|
Ariad Pharmaceuticals Inc.
|Michael M. Morrissey Ph.D.||Chief Executive Officer, President and Director|
|Mark R. Baker J.D.||Chief Executive Officer, Director and Member of Science & Strategy Committee|
Progenics Pharmaceuticals, Inc.
|Werner Lanthaler MBA,MPA||Chief Executive Officer and Member of Management Board|
|€601.0K||Compensation as of Fiscal Year 2013.|